428 related articles for article (PubMed ID: 34595734)
1. Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases.
Arthur-Farraj P; Coleman MP
Neurotherapeutics; 2021 Oct; 18(4):2200-2221. PubMed ID: 34595734
[TBL] [Abstract][Full Text] [Related]
2. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
Conforti L; Gilley J; Coleman MP
Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
[TBL] [Abstract][Full Text] [Related]
3. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
4. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
5. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
[TBL] [Abstract][Full Text] [Related]
6. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
Summers DW; Gibson DA; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
[TBL] [Abstract][Full Text] [Related]
7. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
8. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
[TBL] [Abstract][Full Text] [Related]
9. The chemical biology of NAD
Icso JD; Thompson PR
Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
[TBL] [Abstract][Full Text] [Related]
10. TIR-1/SARM1 inhibits axon regeneration and promotes axon degeneration.
Czech VL; O'Connor LC; Philippon B; Norman E; Byrne AB
Elife; 2023 Apr; 12():. PubMed ID: 37083456
[TBL] [Abstract][Full Text] [Related]
11. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
[TBL] [Abstract][Full Text] [Related]
12. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
[TBL] [Abstract][Full Text] [Related]
13. SARM1 can be a potential therapeutic target for spinal cord injury.
Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1.
Loreto A; Angeletti C; Gu W; Osborne A; Nieuwenhuis B; Gilley J; Merlini E; Arthur-Farraj P; Amici A; Luo Z; Hartley-Tassell L; Ve T; Desrochers LM; Wang Q; Kobe B; Orsomando G; Coleman MP
Elife; 2021 Dec; 10():. PubMed ID: 34870595
[TBL] [Abstract][Full Text] [Related]
15. The SARM1 axon degeneration pathway: control of the NAD
Figley MD; DiAntonio A
Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
[TBL] [Abstract][Full Text] [Related]
16. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
18. Programmed axon degeneration: from mouse to mechanism to medicine.
Coleman MP; Höke A
Nat Rev Neurosci; 2020 Apr; 21(4):183-196. PubMed ID: 32152523
[TBL] [Abstract][Full Text] [Related]
19. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
